Verbatim response from ChatGPT
Short answer Controlled-substance rules make stimulant ADHD medicines (Adderall, Vyvanse, Ritalin/Concerta — Schedule II in the U.S.) more tightly regulated than non‑stimulant treatments. That means telehealth/online prescribing is allowed, but prescribers must follow extra federal and state rules (licensure, identity checks, prescription-drug monitoring, special DEA/telemedicine requirements), and many telemedicine services restrict which meds they’ll prescribe remotely.
How that plays out for patients (what to expect)
- Eligibility and identity: You’ll need a proper evaluation (history, symptom review, past records) and reliable identity verification. Some platforms require you to upload prior records or have an in‑person baseline.
- Licensure and location: The clinician must be licensed in the state or country where you’re located at the time of the visit. That limits cross‑state or international prescribing.
- Controlled‑substance rules: For Schedule II stimulants providers must comply with DEA/state rules: check state Prescription Drug Monitoring Programs (PDMPs), use secure e‑prescribing systems (EPCS), and follow documentation/monitoring requirements (treatment agreements, regular follow‑ups, urine drug testing in some cases).
- Possible limits on refills and modalities: Controlled meds often have shorter refill windows and require in‑person visits or more frequent follow-ups depending on regulations and the prescriber’s practice.
- Non‑stimulant options: Atomoxetine (Strattera) and some ADHD medications that are not scheduled (or are Schedule IV) are easier to prescribe by telehealth in many places.
Regulatory background (U.S. context)
- Ryan Haight Act historically required an in‑person exam before prescribing controlled substances by telemedicine; temporary COVID waivers loosened that. The DEA has since put telemedicine rules in place (including pathways for telemedicine prescribing) — but providers still must meet DEA/state requirements or obtain a telemedicine special registration to prescribe controlled substances without an initial in‑person visit.
- States may add additional restrictions (PDMP checks, limits on first‑time remote prescribing, special consent/agreements).
Practical advice
- Be prepared: have past medical records (past ADHD evaluations, prior prescriptions), and a list of medications/medical history.
- Expect monitoring: regular follow‑ups, PDMP checks, and possibly urine drug testing or pill counts.
- Avoid shady services: don’t use “no‑eval” or overseas pharmacies that send stimulants without a U.S. prescriber — that’s illegal and dangerous.
- Insurance/prior auth: many stimulants (especially brand names like Vyvanse) may require prior authorization or have higher costs.
Telehealth services that commonly treat ADHD (examples)
- Done (getdone.co): Focused on ADHD care; offers structured assessments and ongoing follow‑up. Will prescribe stimulants where state rules and medical appropriateness allow.
- PlushCare (plushcare.com): National telehealth platform with board‑certified physicians and psychiatrists; can prescribe controlled meds in states where allowed and after proper evaluation.
- Teladoc / Livongo behavioral health (teladoc.com): Large network offering psychiatric visits — prescribing follows state/DEA rules and clinician judgment.
- SteadyMD (steadymd.com): Matches you with a dedicated physician for ongoing care; useful if you want a continuous, personal relationship that can include controlled‑substance management (subject to laws).
- Local psychiatrists via Zocdoc or a local health system: Many psychiatrists offer telehealth and are more able to manage/stabilize stimulant treatment long term.
If you tell me your state or country and whether you prefer a primary‑care visit or a specialist (psychiatrist), I can name services available to you and note whether they typically prescribe stimulants there.